There weresignificant differences (p < 0.05) between the 2 groups in terms ofmedical history [angiotensin-converting enzyme inhibitor/angiotensin receptorblocker (ACEI/ARB)], diagnosis at admission (anterior myocardial infarction [MI]), white blood cell (WBC),hsCRP, fasting plasma glucose (FPG), myocardial enzyme [pCKMB, peak value ofmyoglobin (pMYO) and peak value of troponin I (pTNI)], peak value of N-terminalpro-brain natriuretic peptide (pNT-pro BNP), LVESD and LVEF. The gene discussed is NPPB; the disease is myocardial infarction.